NF-κB in cancer therapy
- PMID: 25690730
- DOI: 10.1007/s00204-015-1470-4
NF-κB in cancer therapy
Abstract
The transcription factor nuclear factor kappa B (NF-κB) has attracted increasing attention in the field of cancer research from last few decades. Aberrant activation of this transcription factor is frequently encountered in a variety of solid tumors and hematological malignancies. NF-κB family members and their regulated genes have been linked to malignant transformation, tumor cell proliferation, survival, angiogenesis, invasion/metastasis, and therapeutic resistance. In this review, we highlight the diverse molecular mechanism(s) by which the NF-κB pathway is constitutively activated in different types of human cancers, and the potential role of various oncogenic genes regulated by this transcription factor in cancer development and progression. Additionally, various pharmacological approaches employed to target the deregulated NF-κB signaling pathway, and their possible therapeutic potential in cancer therapy is also discussed briefly.
Similar articles
-
Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways.Curr Stem Cell Res Ther. 2019;14(3):219-225. doi: 10.2174/1574888X13666180723104340. Curr Stem Cell Res Ther. 2019. PMID: 30033874 Review.
-
Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression.Oncogene. 2006 Oct 30;25(51):6817-30. doi: 10.1038/sj.onc.1209942. Oncogene. 2006. PMID: 17072330 Review.
-
Nuclear factor-kappaB activation: from bench to bedside.Exp Biol Med (Maywood). 2008 Jan;233(1):21-31. doi: 10.3181/0707-MR-196. Exp Biol Med (Maywood). 2008. PMID: 18156302 Review.
-
NF-kappaB in cancer--a friend turned foe.Drug Resist Updat. 2004 Feb;7(1):53-67. doi: 10.1016/j.drup.2004.01.003. Drug Resist Updat. 2004. PMID: 15072771 Review.
-
Nuclear factor-kappa B and cancer: its role in prevention and therapy.Biochem Pharmacol. 2002 Sep;64(5-6):883-8. doi: 10.1016/s0006-2952(02)01154-1. Biochem Pharmacol. 2002. PMID: 12213582 Review.
Cited by
-
In Vivo Effects of Bay 11-7082 on Fibroid Growth and Gene Expression: A Preclinical Study.Cells. 2024 Jun 24;13(13):1091. doi: 10.3390/cells13131091. Cells. 2024. PMID: 38994944 Free PMC article.
-
NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses-Therapeutic Perspectives.Cancers (Basel). 2018 Nov 8;10(11):426. doi: 10.3390/cancers10110426. Cancers (Basel). 2018. PMID: 30413032 Free PMC article. Review.
-
Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment.Chin Med. 2022 Jun 18;17(1):74. doi: 10.1186/s13020-022-00633-4. Chin Med. 2022. PMID: 35717380 Free PMC article. Review.
-
Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome.ACS Med Chem Lett. 2016 Jan 15;7(3):250-5. doi: 10.1021/acsmedchemlett.5b00401. eCollection 2016 Mar 10. ACS Med Chem Lett. 2016. PMID: 26985310 Free PMC article.
-
CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.Tumour Biol. 2016 Sep;37(9):12731-12742. doi: 10.1007/s13277-016-5157-0. Epub 2016 Jul 22. Tumour Biol. 2016. PMID: 27448305
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
